|
" Breakthrough business models : "
[edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
949566
|
| Doc. No
|
:
|
b703936
|
| Title & Author
|
:
|
Breakthrough business models : : drug development for rare and neglected diseases and individualized therapies: workshop summary /\ [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies.
|
| Publication Statement
|
:
|
Washington, D.C. :: National Academies Press,, ©2009.
|
| Page. NO
|
:
|
1 online resource (xviii, 132 pages)
|
| ISBN
|
:
|
0309120896
|
|
|
:
|
: 1282083554
|
|
|
:
|
: 6612083557
|
|
|
:
|
: 9780309120890
|
|
|
:
|
: 9781282083554
|
|
|
:
|
: 9786612083556
|
|
|
:
|
0309120888
|
|
|
:
|
9780309120883
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references.
|
| Contents
|
:
|
Introduction and overview -- Current model for financing drug development: from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary.
|
| Abstract
|
:
|
"The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development."
|
| Subject
|
:
|
Drugs-- United States-- Design.
|
| Subject
|
:
|
Orphan drugs-- Government policy-- United States.
|
| Subject
|
:
|
Pharmaceutical policy-- United States.
|
| Subject
|
:
|
Drugs-- Design.
|
| Subject
|
:
|
MEDICAL-- Allied Health Services-- General.
|
| Subject
|
:
|
Orphan drugs-- Government policy.
|
| Subject
|
:
|
Pharmaceutical policy.
|
| Subject
|
:
|
Models, Economic-- United States.
|
| Subject
|
:
|
Orphan Drug Production-- economics-- United States.
|
| Subject
|
:
|
Orphan Drug Production-- trends-- United States.
|
| Subject
|
:
|
Research-- economics-- United States.
|
| Subject
|
:
|
Research-- trends-- United States.
|
| Subject
|
:
|
United States.
|
| Dewey Classification
|
:
|
362.17/820973
|
| LC Classification
|
:
|
RA401.A3B74 2009eb
|
| NLM classification
|
:
|
2009 G-098
|
|
|
:
|
QV 736W835b 2009
|
| Added Entry
|
:
|
Giffin, Robert B.
|
|
|
:
|
Robinson, Sally.
|
|
|
:
|
Wizemann, Theresa M.
|
| Added Entry
|
:
|
Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation.
|
| Parallel Title
|
:
|
Drug development for rare and neglected diseases and individualized therapies
|
| |